Concepedia

Fanglei You

FY

Statistics

Publications

7

Citations

422

H-Index

7

Active since

2004

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Yale University

Stanford University

Fanglei You is an author at Dana-Farber Cancer Institute specializing in molecular oncology, pharmacology, and oncology.

Publications per year

2004–2021

7

Publications

7

Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer

Lyndsay N. Harris, Fanglei You, Stuart J. Schnitt et al. · Clinical Cancer Research · 2007 · 243 citations

Medicine, Oncology, Pharmacology +17

Transcriptional Profiling of Rapamycin-Treated Fibroblasts From Hypertrophic and Keloid Scars

Victor W. Wong, Fanglei You, Michael Januszyk et al. · Annals of Plastic Surgery · 2014 · 47 citations · Full text

Veterinary Medicine, Dermatology, Molecular Biology +17

BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonism

Kristen E. Hurov, Johanna Lahdenranta, Punit Upadhyaya et al. · Journal for ImmunoTherapy of Cancer · 2021 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells

Fanglei You, Lisa Roberts, Soonmo Peter Kang et al. · Journal of Hematology & Oncology · 2008 · 36 citations · Full text

Medicine, Cell Biology, Oncology +17

Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist

Punit Upadhyaya, Johanna Lahdenranta, Kristen E. Hurov et al. · Journal for ImmunoTherapy of Cancer · 2021 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 7